Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

Updated June 21st, 2021

Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation.

NOW
PLAYING
Mom Discovers Inoperable Cancer Six Months After Beating Disease
NOW
PLAYING
Pelé Hospitalized For Chemo Treatment In Colon Cancer Battle
NOW
PLAYING
Cancer Patient's Chemo Surgery Cancelled Three Times Due To COVID
NOW
PLAYING
Teacher Battling Stage IV Ovarian Cancer After Only Weeks of Symptoms
NOW
PLAYING
Rex Tillerson Thought Kidney Cancer Symptoms Were White House Stress
NOW
PLAYING
Mom Battles Breast Cancer Three Times Despite Double Mastectomy

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.